SOST and plasma cell myeloma: For multiple myeloma (MM), often presenting with osteolytic lesions, a positive correlation between the severity of bone disease and circulating levels of serum sclerostin has been found, suggesting that MM-cells utilize sclerostin in the formation of osteolytic lesions17, 18.